SF3B1 and cancer: Herein, we demonstrated that SF3B1 dysregulation clearly affects several cancer hallmarks including apoptosis/proliferation/migration/angiogenesis/splicing pattern and signaling among others, and, of particular clinical relevance, that it could be associated with the development of drug resistance.